跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
凝唯 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Recombinant Coagulation Factor VIII for Injection
Approved
生物制品
Recombinant Coagulation Factor VIII for Injection
Octapharma AB
🇨🇳 National Medical Products Administration
Approval Date
Aug 13, 2024
Approval ID
8cp0AYniC7H
Company
Octapharma AB
Type
生物制品
Approval Details
Approval Id
8cp0AYniC7H
Approval Number
国药准字SJ20240036
Generic Name
注射用重组人凝血因子Ⅷ
Generic Name En
Recombinant Coagulation Factor VIII for Injection
Trade Name
凝唯
Drug Type
生物制品
Dosage Form
注射剂
Strength
250 IU/瓶
Reg Date
2024-08-13
Expired Date
2029-08-12
Company Name
Octapharma AB
Production Company Name
Octapharma AB
Company Detail Path
/organization/octapharma-ab
Production Company Detail Path
/organization/octapharma-ab
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 13, 2024
Approval ID
8cp0AYniC7H
Type
生物制品
Back to NMPA Approvals
